Crossmark

Isorhapontigenin: exploring a promising resveratrol analog for disease management through diverse signaling pathways—a review with computational insights

Crossref DOI link: https://doi.org/10.1007/s00210-025-04176-x

Published Online: 2025-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nazir, Muhammad Muzammil

Mustafa, Ghanva

Saeed, Saira

Ghaffar, Warisha

Ijaz, Muhammad Umar

Ashraf, Asma
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 28 March 2025

Accepted: 11 April 2025

First Online: 17 April 2025

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below